Seneca Biopharma, Inc. logo
Seneca Biopharma, Inc. SNCA
$ 1.66 -1.19%

Seneca Biopharma, Inc. Income Statement 2011-2024 | SNCA

Annual Income Statement Seneca Biopharma, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

538 K 425 K 1.06 M 4.01 M 4.12 M 11.8 M 45 M 39 M 12.3 M 8.06 M

Shares

366 K 366 K 126 K 109 K 69.6 K 58.2 K 55.8 K 46.3 K 37.3 K 31 K

Net Income

-16.3 M -8.35 M -4.92 M -15.7 M -21.1 M -20.9 M -22.6 M -19.8 M -10.1 M -12.5 M

Revenue

13.5 K 15.4 K 260 K 260 K 16.2 K 10.4 K 18.8 K 110 K 408 K 391 K

EBITDA

-10.6 M -8.49 M -8.07 M -13 M -20.3 M -18.8 M -17.1 M -12.3 M -9.95 M -12.8 M

Operating Expenses

10.7 M - - - - - - 12.6 M - 13.4 M

General and Administrative Expenses

8.67 M 4.59 M 4.56 M 5.47 M 7.5 M 6.53 M 8.97 M 5.25 M 4.25 M -

All numbers in USD currency